preview celltrion hc cthc op bn vs bbg
bn like releas late weaker
top-lin cycl prevail result margin compress
expect slew consensu revis go forward
factor partial shipment inflectra remsima
us check ir team howev
view shipment acceler unlik given
lacklust biosimilar penetr per read jnj
thu model bn us inflectra sale vs
street expect bn
weak may sustain current circumst
estim bn sale bn op
reiter under-perform new tp
ep cut align cthc
forecast celltrion inc forecast preview note
weaker topline/margin persist given on-going price competit
albeit cthc manag effort contract renegoti etc
estimate pot chg tp
 chang prev ep
note celltrion healthcar conduct global market sale distribut biolog product
develop celltrion inc master distributorship agreement partnership region
click detail financi
previewop bn despit us inflectra sale
preview celltrion hc cthc op bn vs bbg
bn like releas late weaker top-lin
cycl prevail result margin compress expect slew
consensu revis go forward factor partial
shipment inflectra remsima us check
ir team howev view shipment acceler
unlik given lacklust biosimilar penetr per
read jnj thu model bn us
inflectra sale vs street expect bn
weak may sustain current circumst
estim bn sale bn op
figur previewfurth expect bn op
compani data bloomberg professionaltm servic credit suiss
figur cumul us inflectra sell-in sell-throughan estim
mn inventori carri
reiter under-perform tp cut
cut tp deriv mix dcf
price-to-earnings valuat lower p/e-deriv fair
valu appli valuat discount cti sinc
cthc continu squeez cti sale partner
revis ep sinc align cthc
forecast celltrion inc cti forecast preview note
weaker topline/margin persist given on-going price competit
albeit cthc manag effort contract renegoti etc
figur cthc target price calculationtp cut
figur consensu valuat discount ctivalu discount
rise cthc squeez cti sale partner
bloomberg professionaltm servic
seek busi compani cover research report result investor awar
firm may conflict interest could affect object report investor consid
report singl factor make invest decis
bn csbbg diff yoy grqoq hc sell-in pfizer unadjustedpf sell-through usd mn estim us inflectra sale cthcgradualbiosimilar uptak sell-in unadjustedcthc sell-in mark-uppf sell-thru usdmn estimatedpf inventori carri mnbi mark-to-marketvalu cthc inflectra sell-inpf inventorycarryassum mark-up base casebul casebear casedcf price price hc valuat discount celltrion incavg charl martineau pm univers toronto
compani mention price
ray certifi view express report accur reflect person view subject compani secur
part compens directli indirectli relat specif recommend view express report
price rate histori celltrion healthcar co ltd
signifi initi assumpt coverag
price rate histori celltrion inc
signifi initi assumpt coverag
price rate histori johnson johnson jnj
signifi initi assumpt coverag
price rate histori pfe
signifi initi assumpt coverag
decemb analyst stock rate defin follow
outperform stock total return expect outperform relev benchmark next month
neutral stock total return expect line relev benchmark next month
under-perform stock total return expect under-perform relev benchmark next month
relev benchmark region decemb japanes rate base stock total return rel analyst cove rage univers
consist compani cover analyst within relev sector outperform repres attract neutral less attract
underperform least attract invest opportun octob canadian well european ra ting base stock total return
rel analyst coverag univers consist compani cover analyst within relev sector outperform repres mo st
attract neutral less attract underperform least attract invest opportun latin american asia stock exclud japan
australia rate base stock total return rel averag total return relev countri regio nal benchmark india bse sensex index
prior octob canadian rate base stock absolut total return potenti current share price rel
attract stock total return potenti within analyst coverag univers australian new zealand stoc ks expect total return calcul
includ roll dividend yield outperform rate assign greater equal under-perform wh ere less
equal neutral may assign overlap rate rang allow analyst assign rate put
context associ risk prior may rang outperform under-perform rate overlap ne utral threshold
oper juli
restrict certain circumst credit suiss polici and/or applic law regul preclud certain type commun
includ invest recommend cours credit suiss engag invest bank transact certain
rate nr credit suiss equiti research invest rate view stock secur relat compani
time
cover nc credit suiss equiti research provid on-going coverag compani offer invest rate invest view
equiti secur compani relat product
volatil indic stock defin volatil stock price move month least past
month analyst expect signific volatil go forward
analyst sector weight distinct analyst stock rate base analyst expect fundament and/or valuat
sector rel group histor fundament and/or valuat
overweight analyst expect sector fundament and/or valuat favor next month
market weight analyst expect sector fundament and/or valuat neutral next month
underweight analyst expect sector fundament and/or valuat cautiou next month
analyst coverag sector consist compani cover analyst within relev sector analyst may cov er multipl sector
credit suiss distribut stock rate bank client
bank client
purpos nyse finra rate distribut disclosur requir stock rate outperform neutral under-perform close correspond
